{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:27:16Z","timestamp":1777001236634,"version":"3.51.4"},"reference-count":22,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: To evaluate changes in background parenchymal enhancement (BPE) in the contralateral breast on MRI before and after neoadjuvant chemotherapy (NAC), stratified by molecular subtype in patients with unilateral breast cancer. Methods: This study retrospectively analyzed 116 individuals diagnosed with unilateral breast cancer by biopsy, all of whom underwent breast MRI examinations before and after neoadjuvant chemotherapy. Contralateral breast BPE was graded into four levels (BPEC: 1 = minimal, 2 = mild, 3 = moderate, 4 = marked) by two readers in consensus. Histopathological features and BPE reduction were compared according to molecular subtype. Results: BPE showed a reduction across all molecular subtypes after NAC. In ER-positive cancers, BPEC shifted from 26\/16\/28\/30% to 68\/28\/4\/0%; in HER2-positive cancers, from 37.8\/26.7\/22.2\/13.3% to 73.3\/20.0\/6.7\/0%; and in triple-negative breast cancers, from 47.6\/14.3\/23.8\/14.3% to 76.2\/14.3\/9.5\/0%. Compared to the ER-positive cancer, the reduction in BPE over time was significantly greater in the HER2-positive cancer group (Estimate = 0.48, p = 0.0168) and TNBC (Estimate = 0.55, p = 0.0321), suggesting that the extent of BPE decrease varied by subtype. Conclusions: The extent of BPE reduction on breast MRI following NAC varies significantly across different molecular subtypes of breast cancer.<\/jats:p>","DOI":"10.3390\/diagnostics15222826","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T10:35:31Z","timestamp":1762770931000},"page":"2826","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Contralateral Breast Background Parenchymal Enhancement on MRI Before and After Neoadjuvant Chemotherapy According to Molecular Subtypes in Unilateral Breast Cancer"],"prefix":"10.3390","volume":"15","author":[{"given":"Mi Young","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul 05030, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nami","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul 05030, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surin","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul 05030, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-2878","authenticated-orcid":false,"given":"Jeemin","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul 05030, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Yeon","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul 05030, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-5552","authenticated-orcid":false,"given":"Yoon Joo","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul 05030, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"ref_1","unstructured":"D\u2019Orsi, C.J., Sickles, E.A., Mendelson, E.B., and Morris, E.A. (2013). Magnetic Resonance Imaging. ACR BI-RADS\u00ae Atlas, Breast Imaging Reporting and Data System, American College of Radiology."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S22002","DOI":"10.1117\/1.JMI.12.S2.S22002","article-title":"Impact of menopause and age on breast density and background parenchymal enhancement in dynamic contrast-enhanced magnetic resonance imaging","volume":"12","author":"Kuling","year":"2025","journal-title":"J. Med. Imaging"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2015142304","article-title":"Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?","volume":"276","author":"Dontchos","year":"2015","journal-title":"Radiology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.mri.2015.10.014","article-title":"Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer","volume":"34","author":"Telegrafo","year":"2016","journal-title":"Magn. Reson. Imaging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.acra.2018.03.013","article-title":"Relationship between Background Parenchymal Enhancement on High-risk Screening MRI and Future Breast Cancer Risk","volume":"26","author":"Grimm","year":"2019","journal-title":"Acad. Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1200\/JCO.18.00378","article-title":"Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk","volume":"37","author":"Arasu","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13058-020-01375-7","article-title":"Association of breast cancer with MRI background parenchymal enhancement: The IMAGINE case-control study","volume":"22","author":"Watt","year":"2020","journal-title":"Breast Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.5858\/arpa.2015-0133-RA","article-title":"Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma: A 2015 Update","volume":"140","author":"Tang","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejrad.2019.02.018","article-title":"Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type","volume":"113","author":"Dilorenzo","year":"2019","journal-title":"Eur. J. Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1148\/radiol.15142192","article-title":"Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast Cancer","volume":"276","author":"Dmitriev","year":"2015","journal-title":"Radiology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41523-022-00475-1","article-title":"MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: A systematic review and meta-analysis","volume":"8","author":"Janssen","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1148\/rg.2021200134","article-title":"Breast MRI for Evaluation of Response to Neoadjuvant Therapy","volume":"41","author":"Reig","year":"2021","journal-title":"Radiographics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1148\/radiol.2021203645","article-title":"Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response","volume":"301","author":"Onishi","year":"2021","journal-title":"Radiology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/jbi\/wbaa028","article-title":"Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2- Patients","volume":"2","author":"Arasu","year":"2020","journal-title":"J. Breast Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/0284185114538622","article-title":"Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy","volume":"56","author":"Choi","year":"2015","journal-title":"Acta Radiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s00330-015-4011-x","article-title":"Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: Correlation with tumour response","volume":"26","author":"Preibsch","year":"2016","journal-title":"Eur. Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tranon.2015.04.001","article-title":"Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy","volume":"8","author":"Chen","year":"2015","journal-title":"Transl. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.tranon.2017.07.005","article-title":"Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients","volume":"10","author":"You","year":"2017","journal-title":"Transl. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/0284185117738560","article-title":"Decreased background parenchymal enhancement of the contralateral breast after two cycles of neoadjuvant chemotherapy is associated with tumor response in HER2-positive breast cancer","volume":"59","author":"You","year":"2018","journal-title":"Acta Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10549-018-4801-3","article-title":"Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy","volume":"170","author":"Haque","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e6930","DOI":"10.1002\/cam4.6930","article-title":"Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival","volume":"13","author":"Houvenaeghel","year":"2024","journal-title":"Cancer Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis","volume":"26","author":"Spring","year":"2020","journal-title":"Clin. Cancer Res."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/22\/2826\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T10:48:05Z","timestamp":1762771685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/22\/2826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":22,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["diagnostics15222826"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15222826","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]}}}